Login / Signup
Commentary on "Is posttransplant lenalidomide the standard-of-care after an autotransplant for plasma cell myeloma" by Giovanni Barosi and Robert Peter Gale.
Sarah A Holstein
Vera J Suman
Philip L McCarthy
Published in:
Leukemia (2019)
Keyphrases
</>
multiple myeloma
newly diagnosed
healthcare
single cell
palliative care
cell therapy
quality improvement
stem cell transplantation
pain management
stem cells
affordable care act
low dose
health insurance